Sangamo Therapeutics, Inc. SGMOQ

0.14 (0.01) (6.67%) as of 25 Sep
Market cap
$41.9M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
20.95 41.92 81.00 277.63 376.55 641.42 362.47 400.13 243.31 142.54
Receivables
0.37 0.53 0.92 4.47 6.36 6.26 37.59 5.05 3.58 5.20
Other current assets
10.14 4.07 3.14 18.22 15.86 11.99 5.41 5.34 1.51 1.85
Total current assets
35.83 51.69 94.33 300.33 398.77 659.67 405.47 410.52 248.40 149.58
Property, Plant, Equpment (Net)
11.04 17.89 26.87 63.53 51.52 41.32 29.93 78.72 31.07 6.56
Long-Term Investments
— — — 29.85 88.17 50.53 21.83 3.50 1.01 —
Goodwill and Intangible Assets (Total)
— — — 88.28 93.46 100.93 92.43 94.29 1.59 1.59
Long-term assets (Other)
9.81 15.19 18.13 18.52 16.82 15.06 10.57 6.86 4.68 0.17
Total non-current assets
23.92 49.94 70.99 262.18 323.15 278.88 232.04 179.87 38.34 8.31
Total Assets
59.75 101.64 165.32 562.51 721.92 938.55 637.52 590.40 286.74 157.89
Accounts Payable
14.44 15.49 15.26 22.42 9.76 12.55 6.67 21.46 11.04 6.26
Accrued Expenses
17.72 14.57 8.92 21.51 20.84 20.74 13.61 9.49 5.48 2.89
Current Revenue (Deferred)
0.90 7.56 0.00 51.78 85.71 91.64 38.71 47.56 28.35 4.15
Total current liabilities
42.47 45.81 47.73 111.71 127.89 143.55 69.87 78.51 44.86 13.29
Long Term Debt (Total)
— — — 38.99 44.06 38.40 41.19 27.69 24.74 3.95
Non-current Revenue (Deferred)
5.87 5.87 0.00 109.38 166.78 245.05 81.43 108.27 29.24 4.46
Long Term Tax Liability (Deferred)
— — — 6.27 6.65 7.19 6.57 6.71 — —
Non-current Liabilities (Other)
0.58 0.93 1.19 1.21 1.22 7.01 5.71 1.96 0.00 —
Total non-current liabilities
31.55 33.06 34.70 155.84 218.69 297.64 134.91 144.63 53.98 8.41
Total liabilities
74.01 78.87 82.43 267.55 346.58 441.18 204.78 223.14 98.84 21.70
Additional Paid In Capital
1,610.94 1,532.49 1,492.08 1,450.24 1,334.14 1,269.38 1,090.83 929.63 682.81 576.38
Common Stock (Net)
3.51 2.13 1.78 1.67 1.46 1.42 1.16 1.02 0.86 0.71
Retained Earnings
(1,627.25) (1,504.32) (1,406.38) (1,148.54) (956.27) (777.98) (656.98) (562.70) (495.48) (440.91)
Common Equity (Total)
(14.27) 22.77 82.89 294.96 375.34 497.37 432.74 367.26 187.90 136.20
Shareholders Equity (Total)
(14.27) 22.77 82.89 294.96 375.34 497.37 432.74 367.26 187.90 136.20
Shareholders Equity and Liabilities (Total)
59.75 101.64 165.32 562.51 721.92 938.55 637.52 590.40 286.74 157.89
Shares (Common)
350.69 212.84 178.13 166.79 145.92 142.06 115.97 102.19 85.60 70.87
Shareholders Equity (Tangible)
(14.27) 22.77 82.89 206.68 281.88 396.44 340.31 272.97 186.32 134.61
Net Debt
(20.95) (41.92) (81.00) (238.65) (332.49) (603.03) (321.28) (372.44) (218.57) (138.59)
Total Debt
— — — 38.99 44.06 38.40 41.19 27.69 24.74 3.95

Fold the line items

In millions of $ except per-share values · columns are period end dates